- Home
- AKRO vs HG Comparison
AKRO vs HG Comparison
Compare AKRO & HG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- HG
- Stock Information
- Founded
- AKRO 2017
- HG 2013
- Country
- AKRO United States
- HG Bermuda
- Employees
- AKRO N/A
- HG N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- HG
- Sector
- AKRO Health Care
- HG
- Exchange
- AKRO Nasdaq
- HG Nasdaq
- Market Cap
- AKRO 3.9B
- HG 2.2B
- IPO Year
- AKRO 2019
- HG 2023
- Fundamental
- Price
- AKRO $52.40
- HG $21.09
- Analyst Decision
- AKRO Strong Buy
- HG Buy
- Analyst Count
- AKRO 6
- HG 6
- Target Price
- AKRO $82.50
- HG $23.67
- AVG Volume (30 Days)
- AKRO 1.7M
- HG 498.5K
- Earning Date
- AKRO 08-08-2025
- HG 08-06-2025
- Dividend Yield
- AKRO N/A
- HG N/A
- EPS Growth
- AKRO N/A
- HG N/A
- EPS
- AKRO N/A
- HG 3.03
- Revenue
- AKRO N/A
- HG $2,443,695,000.00
- Revenue This Year
- AKRO N/A
- HG $14.39
- Revenue Next Year
- AKRO N/A
- HG $11.69
- P/E Ratio
- AKRO N/A
- HG $6.99
- Revenue Growth
- AKRO N/A
- HG 27.70
- 52 Week Low
- AKRO $21.34
- HG $15.31
- 52 Week High
- AKRO $58.40
- HG $22.33
- Technical
- Relative Strength Index (RSI)
- AKRO 52.50
- HG 49.27
- Support Level
- AKRO $50.13
- HG $20.67
- Resistance Level
- AKRO $52.73
- HG $21.75
- Average True Range (ATR)
- AKRO 2.09
- HG 0.46
- MACD
- AKRO -0.76
- HG -0.06
- Stochastic Oscillator
- AKRO 34.00
- HG 31.11
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About HG Hamilton Insurance Group Ltd. Class B
Hamilton Insurance Group Ltd is a specialty insurance and reinsurance company. It operates globally, with underwriting operations in London, Dublin, Bermuda, and the United States. It operates three principal underwriting platforms (Hamilton Global Specialty, Hamilton Select and Hamilton Re) that are categorized into two reporting business segments: International and Bermuda.